Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

Phase 4

Completed

• Conditions: Infertility

• Registration Number: NCT00286364
• Lead Sponsor: Rigshospitalet, Denmark

Brief Summary

We want to investigate if early follicular phase downregulation and androgen priming, by use of GnRH antagonist, aromatase inhibitor and hCG before COH in a short protocol, shows signs of improvement compared to standard short antagonist protocol

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-02-01
• Study First Submitted QC: 2006-02-02
• Study First Posted: 2006-02-03
• Status Verified: 2007-04
• Last Update Submitted: 2007-04-20
• Last Update Posted: 2007-04-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

• Indication and wish for IVF/ICSI treatment
• Womens age 20-39 years (both inclusive)
• Regular menstrual cycle within normal range
• Body Mass Index: 18-30 kg/m2 (both inclusive)
• Negative pregnancy test before treatment
• A maximum of 3 earlier IVF/ICSI treatments that did not result in pregnancy

Exclusion Criteria

• serious systemic disease
• Presence of polycystic ovarian syndrome (PCOS)
• Earlier poor response with less than 4 mature follicles
• Earlier participation in the investigation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

The Fertility Clinic 4071, Copenhagen University Hospital Rigshospitalet; 🇩🇰 Copenhagen, Copenhagen East, Denmark